Cargando…

Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer Patients

Hypoxic head and neck tumors respond poorly to radiotherapy and can be identified using gene expression profiles. However, it is unknown whether treatment outcome is driven by acute or chronic hypoxia. Gene expression data of 398 head and neck cancers was collected. Four clinical hypoxia profiles we...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Heijden, Martijn, de Jong, Monique C., Verhagen, Caroline V. M., de Roest, Reinout H., Sanduleanu, Sebastian, Hoebers, Frank, Leemans, C. René, Brakenhoff, Ruud H., Vens, Conchita, Verheij, Marcel, van den Brekel, Michiel W. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520712/ https://www.ncbi.nlm.nih.gov/pubmed/31027242 http://dx.doi.org/10.3390/cancers11040583

Ejemplares similares

Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation
por: van der Heijden, Martijn, et al.
Publicado: (2020)

Ovarian cancer‐derived copy number alterations signatures are prognostic in chemoradiotherapy‐treated head and neck squamous cell carcinoma
por: Essers, Paul B.M., et al.
Publicado: (2020)

Correction: Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy
por: Keek, Simon, et al.
Publicado: (2020)

Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy
por: Keek, Simon, et al.
Publicado: (2020)

Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy
por: Vossen, David M., et al.
Publicado: (2019)

Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint association
por: Vossen, David M., et al.
Publicado: (2018)

Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors
por: de Ruiter, Emma J., et al.
Publicado: (2020)

Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma
por: Navran, Arash, et al.
Publicado: (2023)

Assessing the prognostic value of tumor-infiltrating CD57+ cells in advanced stage head and neck cancer using QuPath digital image analysis
por: de Ruiter, Emma J., et al.
Publicado: (2022)

Resection Margins in Head and Neck Cancer Surgery: An Update of Residual Disease and Field Cancerization
por: Pierik, Annouk S., et al.
Publicado: (2021)

No Evidence for FANCF Gene Silencing in Head-and-Neck Squamous Cell Carcinomas
por: Ameziane, Najim, et al.
Publicado: (2009)

Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity
por: Dohmen, Amy J.C., et al.
Publicado: (2017)

Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma
por: Verhagen, Caroline V.M., et al.
Publicado: (2018)

Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy
por: Weijer, Ruud, et al.
Publicado: (2015)

Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer
por: Bogowicz, Marta, et al.
Publicado: (2020)

At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma
por: Wondergem, Niels E., et al.
Publicado: (2021)

Molecular Detection of Minimal Residual Cancer in Surgical Margins of Head and Neck Cancer Patients
por: Graveland, A. Peggy, et al.
Publicado: (2009)

Genetic Classification of Oral and Oropharyngeal Carcinomas Identifies Subgroups with a Different Prognosis
por: Smeets, Serge J., et al.
Publicado: (2009)

A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma
por: Hussein, Aisha A., et al.
Publicado: (2018)

The Prediction of Biological Features Using Magnetic Resonance Imaging in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: van der Hulst, Hedda J., et al.
Publicado: (2023)

(99m)Tc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy
por: Hoebers, Frank J. P., et al.
Publicado: (2007)

Optimizing Survival Predictions of Hypopharynx Cancer: Development of a Clinical Prediction Model
por: Arends, Coralie R., et al.
Publicado: (2019)

[(18)F]-HX4 PET/CT hypoxia in patients with squamous cell carcinoma of the head and neck treated with chemoradiotherapy: Prognostic results from two prospective trials
por: Sanduleanu, Sebastian, et al.
Publicado: (2020)

Improving decision making in larynx cancer by developing a decision aid: A mixed methods approach
por: Petersen, Japke F., et al.
Publicado: (2019)

RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated Hypoxia-Inducible Factor-2α
por: van Hagen, Martijn, et al.
Publicado: (2010)

Hypoxia-Induced Mesenchymal Stem Cells Exhibit Stronger Tenogenic Differentiation Capacities and Promote Patellar Tendon Repair in Rabbits
por: Chen, Guanyin, et al.
Publicado: (2020)

Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer
por: Van den Eynden, G G, et al.
Publicado: (2005)

A comprehensive assessment protocol including patient reported outcomes, physical tests, and biological sampling in newly diagnosed patients with head and neck cancer: is it feasible?
por: van Nieuwenhuizen, Annette J., et al.
Publicado: (2014)

The course of health-related quality of life from diagnosis to two years follow-up in patients with oropharyngeal cancer: does HPV status matter?
por: Korsten, Laura H. A., et al.
Publicado: (2021)

Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus–Positive Oropharyngeal Carcinoma
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Hypoxia. Hypoxia, hypoxia inducible factor and myeloid cell function
por: Walmsley, Sarah R, et al.
Publicado: (2009)

Interaction of functional and participation issues on quality of life after total laryngectomy
por: Leemans, Maartje, et al.
Publicado: (2020)

The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma
por: Nauta, Irene H., et al.
Publicado: (2021)

Hypoxia negatively affects senescence in osteoclasts and delays osteoclastogenesis
por: Gorissen, Ben, et al.
Publicado: (2018)

Hypoxia PET Imaging with [18F]-HX4—A Promising Next-Generation Tracer
por: Sanduleanu, Sebastian, et al.
Publicado: (2020)

NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models
por: Gruijs, Mandy, et al.
Publicado: (2021)

Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer
por: Zerp, Shuraila F., et al.
Publicado: (2015)

Hypoxia and oxidative stress in breast cancer: Hypoxia signalling pathways
por: Pugh, Christopher W, et al.
Publicado: (2001)

Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis
por: Beyer, Christian, et al.
Publicado: (2009)

Hypoxia and Hypoxia-Inducible Factors in Leukemias
por: Deynoux, Margaux, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_20gvfahsnt2kgftj3bnqfckg1p